Monty Pal

What it Takes to Close the Gap in Pediatric Cancer Care with Leo Wang, M.D., Ph.D.

City of Hope, Academic Clinical Research, CAR T‑cell therapy gene therapy

In this episode, Leo Wang, M.D., Ph.D., pediatric oncologist, Clinical Director of the Gene Therapy Program and Director of the City of Hope Alpha Clinic, discusses the realities of caring for children with cancers that still have few effective treatments. He reflects on what it takes to begin chang…

Apr 21^st • 46 mins listen

Monty Pal

Reengineering CAR T for Solid Tumors: What Glioblastoma Has Taught Us with Christine Brown, Ph.D.

City of Hope, Academic Research, CAR T-cell, Solid Tumor, Glioblastoma, brain tumor

In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Christine Brown, Ph.D., Deputy Director of the T Cell Research Laboratory at City of Hope, joins Monty Pal, M.D., F.A.S.C.O., to discuss how years of research in glioblastoma, one of the most aggressive and difficult brain ca…

Apr 6^th • 42 mins listen

Monty Pal

Rewriting the Rules of Cellular Therapy

City of Hope, Academic Research, hematologic, immunotherapy, CAR-T, cell therapy

Dr. Stephen Forman shares the past, present, and future of cellular therapy and how City of Hope is building care systems to reach more patients.

Jul 21^st • 47 mins listen

Monty Pal

Expanding the Reach of TIL Therapy: What Will it Take?

City of Hope, Academic Research, melanoma

Dr. Mahuron shares how tumor-infiltrating lymphocyte (TIL) therapy is evolving to reach more patients and improve cancer outcomes.

Aug 4^th • 38 mins listen

The Oncology Nursing Podcast

Experiences With CAR T-Cell Therapy

Kathleen Wiley, RN, MSN, AOCNS®, oncology clinical specialist at ONS, sits down with Megan Harvey, MSN, RN, clinical nurse at the Hospital of the University of Pennsylvania, to discuss Harvey's experience with CAR T-cell therapy. Find out more about this immunotherapy treatment in ca…

Oct 24^th • 14 mins listen

The Oncology Nursing Podcast

How CAR and Other T Cells Are Revolutionizing Cancer Treatment

ONS member Cecily Snyder, BSN, RN, OCN®, BMTCN®, transplant case manager of the blood and marrow transplantation program at Nebraska Medicine in Omaha and member of the Metro Omaha ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss T-cell therapy…

Jan 24^th • 27 mins listen

The Oncology Nursing Podcast

CAR T-Cell Therapy for Hematologic Malignancies Requires Education and Navigation

“Just like with anything we do in oncology, a lot of education is required. Nurses and coordinators are critical to start the education and provide effective resources that are reinforced throughout the treatment,” ONS member Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, F…

May 24^th • 40 mins listen

Monty Pal

How Engineered Antibodies and Next Generation Imaging Tools are Reshaping Cancer Care with Anna Wu, Ph.D.

City of Hope, Academic Research, engineered antibodies, PET, imaging, radioisotope, CEA directed agent, PSCA targeted radiopharmaceutical, pancreatic cancer, prostate cancer

In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Anna Wu, Ph.D., Chair of the Department of Immunology and Theranostics at City of Hope, joins host Monty Pal, M.D., for an engaging discussion on how innovations in antibody engineering and imaging are improving clinicians’…

Mar 9^th • 42 mins listen

The Oncology Nursing Podcast

Oncology Pharmacology 2023: Today’s Treatments and Tomorrow’s Breakthroughs

CDER, FDA, Nurses, biomarker, immunomodulatory

Highlights From Today’s Episode “Full approval through the Center for Drug Evaluation and Research (CDER) and FDA means that those drugs have gone through the laboratory testing, human clinical trial testing, and very extensive clinical trials to make sure that they are effective and th…

Mar 30^th • 53 mins listen